362 related articles for article (PubMed ID: 17986493)
1. Cardiac-resynchronization therapy in heart failure with narrow QRS complexes.
Beshai JF; Grimm RA; Nagueh SF; Baker JH; Beau SL; Greenberg SM; Pires LA; Tchou PJ;
N Engl J Med; 2007 Dec; 357(24):2461-71. PubMed ID: 17986493
[TBL] [Abstract][Full Text] [Related]
2. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR
J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768
[TBL] [Abstract][Full Text] [Related]
3. Dyssynchrony, contractile function, and response to cardiac resynchronization therapy.
Knappe D; Pouleur AC; Shah AM; Cheng S; Uno H; Hall WJ; Bourgoun M; Foster E; Zareba W; Goldenberg I; McNitt S; Pfeffer MA; Moss AJ; Solomon SD;
Circ Heart Fail; 2011 Jul; 4(4):433-40. PubMed ID: 21602574
[TBL] [Abstract][Full Text] [Related]
4. Assessment of resynchronization therapy on functional status and quality of life in patients requiring an implantable defibrillator.
Pinter A; Mangat I; Korley V; Connolly S; Connors S; Gardner M; Philippon F; Sterns L; Thibault B; Dorian P
Pacing Clin Electrophysiol; 2009 Dec; 32(12):1509-19. PubMed ID: 19765233
[TBL] [Abstract][Full Text] [Related]
5. Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure.
Herweg B; Ilercil A; Cutro R; Dewhurst R; Krishnan S; Weston M; Barold SS
Am J Cardiol; 2007 Jul; 100(1):90-3. PubMed ID: 17599447
[TBL] [Abstract][Full Text] [Related]
6. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.
Abraham WT; Young JB; León AR; Adler S; Bank AJ; Hall SA; Lieberman R; Liem LB; O'Connell JB; Schroeder JS; Wheelan KR;
Circulation; 2004 Nov; 110(18):2864-8. PubMed ID: 15505095
[TBL] [Abstract][Full Text] [Related]
7. The benefits of biventricular pacing in heart failure patients with narrow QRS, NYHA class II and right ventricular pacing.
Ng K; Kedia N; Martin D; Tchou P; Natale A; Wilkoff B; Starling R; Grimm RA
Pacing Clin Electrophysiol; 2007 Feb; 30(2):193-8. PubMed ID: 17338715
[TBL] [Abstract][Full Text] [Related]
8. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy.
Belardinelli R; Capestro F; Misiani A; Scipione P; Georgiou D
Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):818-25. PubMed ID: 17001224
[TBL] [Abstract][Full Text] [Related]
9. Randomized comparison of simultaneous biventricular stimulation versus optimized interventricular delay in cardiac resynchronization therapy. The Resynchronization for the HemodYnamic Treatment for Heart Failure Management II implantable cardioverter defibrillator (RHYTHM II ICD) study.
Boriani G; Müller CP; Seidl KH; Grove R; Vogt J; Danschel W; Schuchert A; Djiane P; Biffi M; Becker T; Bailleul C; Trappe HJ;
Am Heart J; 2006 May; 151(5):1050-8. PubMed ID: 16644335
[TBL] [Abstract][Full Text] [Related]
10. A randomized study of cardiac resynchronization therapy defibrillator versus dual-chamber implantable cardioverter-defibrillator in ischemic cardiomyopathy with narrow QRS: the NARROW-CRT study.
Muto C; Solimene F; Gallo P; Nastasi M; La Rosa C; Calvanese R; Iengo R; Canciello M; Sangiuolo R; Diemberger I; Ciardiello C; Tuccillo B
Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):538-45. PubMed ID: 23592833
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of QRS duration to predict response to cardiac resynchronization therapy in patients with end-stage heart failure.
Mollema SA; Bleeker GB; van der Wall EE; Schalij MJ; Bax JJ
Am J Cardiol; 2007 Dec; 100(11):1665-70. PubMed ID: 18036366
[TBL] [Abstract][Full Text] [Related]
12. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
[TBL] [Abstract][Full Text] [Related]
13. CRT plus ICD in congestive heart failure. Use of cardiac resynchronization therapy and an implantable cardioverter-defibrillator in heart failure patients with abnormal left ventricular dysfunction.
Aronow WS
Geriatrics; 2005 Feb; 60(2):24, 26-8. PubMed ID: 15742919
[TBL] [Abstract][Full Text] [Related]
14. Three years of cardiac resynchronization therapy: could superior benefits be obtained in patients with heart failure and narrow QRS?
Gasparini M; Regoli F; Galimberti P; Ceriotti C; Bonadies M; Mangiavacchi M; Andreuzzi B; Bragato R; Pini D; Klersy C; Gronda E
Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S34-9. PubMed ID: 17302713
[TBL] [Abstract][Full Text] [Related]
15. Benefit of combined resynchronization and defibrillator therapy in heart failure patients with and without ventricular arrhythmias.
Ypenburg C; van Erven L; Bleeker GB; Bax JJ; Bootsma M; Wijffels MC; van der Wall EE; Schalij MJ
J Am Coll Cardiol; 2006 Aug; 48(3):464-70. PubMed ID: 16875970
[TBL] [Abstract][Full Text] [Related]
16. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
Bonanno C; Ometto R; Pasinato S; Finocchi G; La Vecchia L; Fontanelli A
Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900
[TBL] [Abstract][Full Text] [Related]
17. Predictors of response to cardiac resynchronization therapy--importance of left ventricular dyssynchrony.
Santos JF; Parreira L; Madeira J; Seixo F; Mendes L; Lopes C; Venâncio J; Lourenço J; Caetano F; Inês L; Mendes M
Rev Port Cardiol; 2006 Jun; 25(6):569-81. PubMed ID: 17019976
[TBL] [Abstract][Full Text] [Related]
18. Metaanalysis on effects of cardiac resynchronization therapy in heart failure patients with narrow QRS complex.
Jeevanantham V; Zareba W; Navaneethan S; Fitzgerald D; Yu CM; Achilli A; Bax J; Daubert J
Cardiol J; 2008; 15(3):230-6. PubMed ID: 18651415
[TBL] [Abstract][Full Text] [Related]
19. Cardiac resynchronization therapy reduces the risk of cardiac events in patients with diabetes enrolled in the multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy (MADIT-CRT).
Martin DT; McNitt S; Nesto RW; Rutter MK; Moss AJ
Circ Heart Fail; 2011 May; 4(3):332-8. PubMed ID: 21350054
[TBL] [Abstract][Full Text] [Related]
20. Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial.
Cleland J; Freemantle N; Ghio S; Fruhwald F; Shankar A; Marijanowski M; Verboven Y; Tavazzi L
J Am Coll Cardiol; 2008 Aug; 52(6):438-45. PubMed ID: 18672164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
